(Total Views: 103)
Posted On: 06/14/2021 1:20:48 PM
Post# of 15417

$EYEG News Article - EyeGate Pharma Announces First Patient Dosed for PP-001 in a Phase 2 Proof-of-Concept Ocular Surface Inflammation Study https://marketwirenews.com/news-releases/eyeg...91167.html


My Twitter: WhyteStocks